Cipla Health

What Cipla Health does

Cipla Health Limited (legal entity: CHL Health Limited) is a wholly-owned subsidiary of Indian pharmaceutical major Cipla Limited, operating as the group's consumer healthcare arm since spinning off as a separate entity in 2016. The company develops, manufactures, and markets over-the-counter (OTC) wellness products across more than ten therapeutic and lifestyle categories in India, including smoking cessation (Nicotex nicotine gums, lozenges, and patches powered by Nicotine Replacement Therapy), throat and respiratory care (Cofsils lozenges, syrups, cough drops, and antiseptic gargle), pain management (Omnigel with Diclofenac, Paracip paracetamol), oral rehydration (ProlyteORS with WHO-recommended formulation), nutrition and supplements (Maxirich, Unobiotics probiotics with microbac technology and Lactobacillus rhamnosus GG strain, ActivKids, Endura Mass), maternal care (MamaXpert), antiseptic and antifungal solutions (Cipladine, Clocip), nasal decongestion (Naselin), and hand hygiene (CipHands). Its technology stack centers on formulation science rather than software, with proprietary or specialized delivery technologies (NRT protocols, microbac encapsulation, WHO ORS standards, Diclofenac topical formula) underpinning brand claims.

The company sells through a multi-channel distribution model spanning pharmacy retail, modern trade (large retail chains under a dedicated Modern Trade channel), e-commerce, and food-delivery partnerships with Swiggy, Zomato, and Dunzo launched during the COVID-19 pandemic. Acquisitions of Endura Mass (2022) and Ivia Beaute's beauty distribution business with brands Astaberry, Ikin, and Bhimsaini (2024, ₹130 crore plus ₹110 crore contingent) have extended the portfolio into weight-gain nutrition and cosmetics/personal care, particularly targeting Tier 2-6 Indian cities. Top brands Nicotex, Cofsils, Prolyte ORS, and Omnigel each generate ₹200-400 crore in annual revenue, and the company reported total FY25 revenue of ₹1,220 crore (~$145M). The company has stated a target of 2-3x growth in five years by expanding into sexual wellness and premium skincare segments.

Name

Cipla Health

Legal name

CHL Health Limited

Website

https://ciplahealth.in

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Cipla Health is a wholly-owned consumer healthcare subsidiary of Cipla Limited, marketing OTC wellness products across smoking cessation, throat care, pain management, hydration, nutrition, and maternal care in India. FY25 revenue was ₹1,220 crore, with top brands Nicotex, Cofsils, Prolyte ORS, and Omnigel each generating ₹200-400 crore.

Ownership category

akta.pro rank

Product category

Consumer Healthcare (OTC)

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (4242), Soap and Cleaning Compound Manufacturing (32561)

SIC

Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Smoking Cessation & Nicotine Replacement Therapy (Gum, Patches, Lozenges) (CRADAMAI)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE), Vitamins & Minerals (Single Nutrients) (CRADAGAB), Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests) (CRADAMAH)

Keywords

• Consumer healthcare products
• OTC pharmaceuticals
• Smoking cessation therapy
• Pain management products
• Nutritional supplements

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Technology or R&D, Operations

Revenue model

1. OTC Consumer Healthcare Products: Cipla Health generates revenue through the sale of over-the-counter healthcare and wellness products across categories including smoking cessation (Nicotex), pain care (Omnigel), cough and cold (Cofsils), oral rehydration (Prolyte ORS), antiseptic (Cipladine), skincare (Clocip), nasal care (Naselin), nutrition (Maxirich), probiotics (Unobiotics), maternal care (MamaXpert), and hand hygiene (Ciphands). The company reported FY25 revenue of ₹1,220 crore.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Cipla Health develops, manufactures, and commercialises a portfolio of branded over-the-counter (OTC) consumer healthcare products across multiple categories including smoking cessation (Nicotex), pain management (Omnigel, Paracip), cough and cold (Cofsils lozenges, syrups, cough drops, gargle), oral rehydration (ProlyteORS), antiseptic care (Cipladine), antifungal care (Clocip), nasal care (Naselin), nutritional supplements (Maxirich, Unobiotics, ActivKids, Endura Mass), maternal care (MamaXpert), hand hygiene (CipHands), and beauty/personal care (Astaberry, Ikin, Bhimsaini). The company sells directly to Indian consumers through pharmacy retail, modern trade, e-commerce, and food delivery partnerships.

Product overview

Cipla Health is a consumer healthcare company and wholly-owned subsidiary of Cipla Limited, offering a diverse portfolio of wellness and OTC products across multiple categories including pain management (Omnigel, Paracip), antiseptic care (Cipladine), respiratory/throat care (Cofsils lozenges, syrups, drops, gargle; Naselin), smoking cessation (Nicotex gums, lozenges, patches), hydration (ProlyteORS), nutrition/supplements (Maxirich, Unobiotics, ActivKids, Endura Mass), maternal care (MamaXpert), antifungal care (Clocip), hand hygiene (CipHands), and beauty/personal care (Astaberry, Ikin, Bhimsaini). The company operates as a research-driven startup that launched in 2015 and spun off as a separate entity in 2016, with a mission to become the most preferred consumer healthcare brand globally. The portfolio includes both organically developed brands and acquired brands, with top brands Nicotex, Cofsils, Prolyte ORS, and Omnigel each earning Rs 200-400 crore annually, and the company targeting 2-3x growth over five years by expanding into sexual wellness and premium skincare segments.

Differentiator

Problem solved

Functional benefit

Brands

• Nicotex: Flagship smoking cessation brand offering nicotine replacement therapy products including gums, lozenges and patches.
• Cofsils
• Omnigel
• Prolyte ORS
• MamaXpert
• Maxirich
• Unobiotics
• Ciphands
• Clocip
• Naselin
• Cipladine
• Paracip

Products and services

• Omnigel India's No.1 pain recovery gel powered by a Diclofenac formula that acts at the root of pain, providing not only instant pain relief but also faster recovery from inflammation. For adults with body aches, joint pains, and inflammation.
• Cipladine India's No.1 medicated antiseptic topical solution powered by Povidone-Iodine for rapid microbicidal action. Used as first-aid for cuts, wounds, burns, and infections.
• Naselin Nasal decongestant that unblocks the nose and decongests sinuses, providing relief from heaviness in head and stuffiness especially when sinuses are affected.
• Clocip Antifungal solution formulated with 1% Clotrimazole for treating skin infections like athlete's foot, jock itch, ringworm, and underarm infections. Available as powder and cream.
• CipHands Hand hygiene brand offering sanitizers, hand rubs, and surface sprays to keep users protected from germs at all times.
• Unobiotics Premium probiotic supplement using microbac technology that delivers 5 times more probiotic activity than traditional formats. Contains Lactobacillus rhamnosus GG strain for digestive health and immunity.
• MamaXpert India's first Specialist Pregnancy Care Brand providing comprehensive products for pre-pregnancy, during pregnancy, and post-pregnancy stages including pregnancy detection kits, intimate wash, stretch mark cream, and nipple cream.
• Maxirich Daily health supplement with more than 13 essential vitamins and minerals in softgel capsules. Includes Maxirich Gold (with ginseng), Daily Multivitamin, Multivitamin Syrup, LiverCare, Cal500, and Vitamin C+Zinc variants.
• ProlyteORS WHO-recommended ORS formulation that helps in quick recovery from dehydration and restores body fluids and electrolytes. Contains water, glucose, sodium, potassium and citrate blend.
• Cofsils Lozenge Triple-relief lozenge with antiviral, antibacterial, and soothing properties providing quick relief from sore throat in just 5 minutes, lasting up to 2 hours. Available in 6 flavors.
• Cofsils Cough Syrup Range of cough syrups providing 3-way action on cough, cold, and sore throat with quick relief. Available in Natural (11 natural ingredients, non-drowsy, alcohol-free) and Medicated variants.
• Cofsils Cough Drops Cough drops with goodness of 41 natural herbs providing quick relief from sore throat, cough, and irritation. Available in 4 flavors: menthol, ginger, honey, and tulsi.
• Cofsils Experdine Gargle Antiseptic and disinfectant mouthwash with povidone-iodine 2% w/v scientific formula that kills germs causing throat infection in 30 seconds, providing instant relief from tonsillitis and pharyngitis.
• Nicotex India's No.1 Doctor recommended smoking cessation brand powered by Nicotine Replacement Therapy (NRT). Offers range of gums, lozenges, and patches that help quit smoking in 12 weeks by gradually reducing nicotine intake.
• Paracip Paracetamol range available in Tablets (500mg, 650mg), Syrup (250mg, 125mg), and Drops (150mg) formats for mild to severe body pains and fever. Gentle on stomach.
• ActivKids Product line designed to enhance the immune system to help the growth of children.
• Endura Mass Nutritional supplement brand acquired from Medinnbelle Herbalcare Private Limited, expanding wellness portfolio into the weight gain category for underweight individuals in India.
• Astaberry Cosmetics brand acquired as part of Ivia Beaute acquisition, strengthening presence in beauty and personal care sector across Tier 2-6 cities in India.
• Ikin Cosmetics brand acquired as part of Ivia Beaute acquisition for beauty and personal care expansion across Tier 2-6 cities in India.
• Bhimsaini Cosmetics brand acquired as part of Ivia Beaute acquisition for beauty and personal care expansion across Tier 2-6 cities in India.

Quantifiable outcome

• Nicotex NRT doubles the chances of quitting smoking
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered minor and core.

• Indian Medical AssociationminorStrategic or Co-development Partner · 1 June 2026Partnership with Indian Medical Association for World No Tobacco Day screening and awareness initiatives to promote tobacco cessation and early detection of tobacco-related health risks
• Saveetha Dental CollegeminorStrategic or Co-development Partner · 1 June 2026Partnership with Saveetha Dental College for oral health check-ups during World No Tobacco Day screening campaigns in Chennai
• Krishnadevaraya College of Dental Science & HospitalminorStrategic or Co-development Partner · 1 June 2026Partnership with Krishnadevaraya College of Dental Science & Hospital for lung health assessments and tobacco-related risk screenings during World No Tobacco Day initiatives
• SwiggycoreGTM or Marketing Partner · 15 April 2020Cipla Health partnered with Swiggy for home delivery of OTC wellness products during COVID-19 pandemic, enabling consumers to access essential wellness offerings through food delivery app
• ZomatocoreGTM or Marketing Partner · 15 April 2020Cipla Health partnered with Zomato for home delivery of OTC wellness products, extending product availability to consumers through the food delivery platform during pandemic
• DunzocoreGTM or Marketing Partner · 15 April 2020Cipla Health partnered with Dunzo for quick delivery of OTC wellness products, providing consumers with rapid access to essential health products through the delivery service

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Dabur India: One of India's largest consumer healthcare and OTC companies with a portfolio spanning health supplements, oral care, and personal care. Directly comparable to Cipla Health in the OTC consumer healthcare space with much larger scale, similar multi-category brand strategy, and pan-India distribution.
• Patanjali Ayurved: Major Indian FMCG and Ayurvedic OTC player with a wide consumer healthcare portfolio including cough/cold, nutrition, and personal care. Competes directly with Cipla Health's ProlyteORS, Cofsils, and Maxirich lines with significant pricing pressure and mass-market distribution.
• Emami Limited: Indian consumer healthcare company with leading OTC and personal care brands across categories like pain management (Zandu), skincare, and wellness. Comparable to Cipla Health's category-spanning OTC strategy and pan-India retail distribution model.
• Marico Limited: Indian FMCG major with healthcare and wellness portfolio including edible oils, hair care, and nutritional supplements. Comparable in operating model (multi-brand consumer health) and distribution infrastructure through pharmacy and modern trade.
• Procter & Gamble Health: India-focused subsidiary of P&G operating in vitamins, supplements, and OTC health (Vicks, Neurobion, SevenSeas). Comparable in OTC consumer healthcare focus and India market, though part of a much larger global portfolio.
• GlaxoSmithKline Consumer Healthcare: Now Haleon, the global OTC consumer healthcare major with major India presence in oral health, nutrition, and wellness. Comparable to Cipla Health in category diversity and pharmacy distribution dominance in India.

Direct peers

• Himalaya Wellness: Indian OTC consumer healthcare company specializing in herbal pharma and personal care products across categories including wellness, nutrition, and skincare. Closely comparable to Cipla Health's portfolio breadth across smoking cessation alternatives, oral care, and wellness supplements.
• Mankind Pharma: India's fourth-largest pharmaceutical company with significant OTC consumer healthcare presence across categories. Directly comparable to Cipla Health in OTC product portfolio strategy, distribution model, and India-focused consumer healthcare market positioning.
• Zydus Wellness: Consumer healthcare subsidiary of Zydus Cadila focused on health and wellness products including nutrition (Complan, Glucon-D, Sugar Free) and personal care. Highly comparable business model — pharma parent's consumer healthcare arm — with similar brand-led OTC strategy.

Regional players

• Hamdard Laboratories: Indian OTC consumer healthcare and Unani medicine company with brands like Rooh Afza and Safi. Comparable in OTC consumer healthcare positioning and India-focused distribution with strong regional heritage brands.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ciplahealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cipla Health